Cargando…
A mouse model featuring tissue-specific deletion of p53 and Brca1 gives rise to mammary tumors with genomic and transcriptomic similarities to human basal-like breast cancer
PURPOSE AND METHODS: In human basal-like breast cancer, mutations and deletions in TP53 and BRCA1 are frequent oncogenic events. Thus, we interbred mice expressing the CRE-recombinase with mice harboring loxP sites at TP53 and BRCA1 (K14-Cre; p53(f/f) Brca1(f/f)) to test the hypothesis that tissue-s...
Autores principales: | Hollern, Daniel P., Contreras, Cristina M., Dance-Barnes, Stephanie, Silva, Grace O., Pfefferle, Adam D., Xiong, Jessie, Darr, David B., Usary, Jerry, Mott, Kevin R., Perou, Charles M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6418066/ https://www.ncbi.nlm.nih.gov/pubmed/30484104 http://dx.doi.org/10.1007/s10549-018-5061-y |
Ejemplares similares
-
Luminal progenitor and fetal mammary stem cell expression features predict breast tumor response to neoadjuvant chemotherapy
por: Pfefferle, Adam D., et al.
Publicado: (2015) -
Increased gene expression variability in BRCA1-associated and basal-like breast tumours
por: Wiggins, George A. R., et al.
Publicado: (2021) -
The MMTV-Wnt1 murine model produces two phenotypically distinct subtypes of mammary tumors with unique therapeutic responses to an EGFR inhibitor
por: Pfefferle, Adam D., et al.
Publicado: (2019) -
Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes
por: Prat, Aleix, et al.
Publicado: (2013) -
PDGFRβ is an essential therapeutic target for BRCA1-deficient mammary tumors
por: Bai, Feng, et al.
Publicado: (2021)